|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.62 CNY | -1.04% |
|
+6.44% | -26.28% |
Xiwei'ai Pharmaceutical Technology (Shanghai) Co., Ltd. signed a capital increase agreement to receive CNY 30 million in funding on July 21, 2021. The transaction will include participation from new investor Wuhan Hiteck Biological Pharma Co., Ltd. which will acquire 13.6363% stake. The pre money valuation of the company is CNY 190 million.
The transaction does not need to be submitted to the board of directors and the general meeting of shareholders of investor for deliberation.
| 1st Jan change | Capi. | |
|---|---|---|
| -26.28% | 487M | |
| +32.36% | 698B | |
| +26.51% | 568B | |
| -4.40% | 358B | |
| +19.46% | 328B | |
| +3.50% | 283B | |
| +16.34% | 238B | |
| +6.68% | 203B | |
| -9.08% | 198B | |
| +8.62% | 165B |
WUHAN HITECK BIOLOGICAL PHARMA CO.,LTD 